Results 1 -
10
of
13
for
Talazoparib
- Talazoparib is used alone to treat certain types of breast cancer that has spread within the breast or to other areas of the body. Talazoparib is also used with enzalutamide (Xtandi) to treat ...
- This page lists cancer drugs approved by the Food and Drug Administration (FDA) for prostate cancer. The list includes generic names and brand names. ... Prostate ...
- Breast cancer treatment depends on several factors and can include combinations of surgery, chemotherapy, radiation, hormone, and targeted therapy. Learn ...
- Cancer/Treatments and Therapies ... Cancer ... Cancer Chemotherapy/Start Here ... Cancer Chemotherapy ... National Cancer Institute ... From the National Institutes of Health ... List ...
- Breast Cancer/Treatments and Therapies ... Breast Cancer ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved ...
- Find what's new in prostate cancer research, including current progress in improving biopsies and imaging for diagnosis, and in treating prostate cancer ...
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
(National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases)
Medicines/Statistics and Research ... Medicines ... Liver Diseases/Statistics and Research ... Liver Diseases ... LiverTox® provides regularly updated, unbiased and easily ... - Breastfeeding/Statistics and Research ... Breastfeeding ... National Library of Medicine ... The LactMed® database contains information on drugs and other chemicals ...
- Breast Cancer/Genetics ... Breast Cancer ... Ovarian Cancer/Genetics ... Ovarian Cancer ... Genetic Testing/Specifics ... Genetic Testing ... National Cancer Institute ... From the National ...
- What's New in Prostate Cancer Research and Treatment? (American Cancer Society)Prostate Cancer/Statistics and Research ... Prostate Cancer ... American Cancer Society ... Research into the causes, prevention, detection, and treatment of prostate ...